Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 992 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Insomnia Disorders Clear all

Conditions: Autism Spectrum Disorders
Interventions: Sound to Sleep System; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 30 Months to 13 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Insomnia
Interventions: Placebo, Ramelteon; Drug
Lead sponsor: Accelerated Community Oncology Research Network; Other
Eligibility: 21 Years to 60 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 10
States / cities: Hot Springs, Arkansas • La Verne, California • Norwich, Connecticut + 7 more

Conditions: Sleep Problems, Insomnia
Interventions: Tart Cherry Juice, Placebo juice; Other
Lead sponsor: Courtney Millar; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Roslindale, Massachusetts

Conditions: Insomnia
Interventions: Bedtime routine, Sleep schedule, Intervention (bedtime), Intervention (after night wakings); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 6 Months to 18 Months
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Sleep Disturbance
Interventions: Sleep Supplement, Placebo; Dietary Supplement · Drug
Lead sponsor: Bonafide Health; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Harrison, New York

Conditions: Brain Injuries, Traumatic, Sleep Initiation and Maintenance Disorders
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Sleep Disturbances
Interventions: S-Adenosyl Methionine (SAMe), Propyl Gallate, Gamma-Aminobutyric Acid (GABA), L-Theanine, and Magnesium Glycinate; Dietary Supplement
Lead sponsor: Bonafide Health; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Harrison, New York

Conditions: Alcohol Use Disorder, Insomnia
Interventions: Web-Based Insomnia Education Program, SHUTi Intervention; Behavioral
Lead sponsor: Jessica Weafer; Other
Eligibility: 21 Years to 50 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Insomnia
Interventions: zolpidem tartrate; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 21 Years to 64 Years
Enrollment: 372 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Depression, Major Depressive Disorder, MDD, Insomnia
Interventions: suvorexant, Placebo; Drug
Lead sponsor: Institute for Advanced Medical Research, Alpharetta, GA; Other
Eligibility: 18 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Atlanta, Georgia • Augusta, Georgia

Conditions: Distress, Emotional, Depression, Anxiety, Fatigue, Pain, Insomnia
Interventions: Individualized Evidence-Based Therapy in Cancer (Patients and Caregivers), Training in Individualized Evidence-Based Therapy in Cancer (Therapists); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer Survivorship, Sleep Disturbances
Interventions: Latin Dance; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Insomnia, Primary Insomnia, Chronic Insomnia
Interventions: Multiple Sleep Latency Test (MSLT); Behavioral
Lead sponsor: Jack Edinger, PhD; Other
Eligibility: 21 Years to 80 Years
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Depression, Insomnia
Interventions: Cognitive Behavioral Therapy for Insomnia, Cognitive Behavioral Therapy for Depression, Mood Monitoring; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 1,175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Insomnia
Interventions: eszopiclone; Drug
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: TBI (Traumatic Brain Injury)
Interventions: InFuSE, Patient Education/Group Discussion; Behavioral
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Chronic Insomnia, Adults, Elderly
Interventions: E2006, Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 29
States / cities: Glendale, Arizona • Phoenix, Arizona • Fountain Valley, California + 21 more

Conditions: Sleep Disturbance, Insomnia
Interventions: Remote Cognitive Behavioral Therapy for Insomnia; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Obesity, Women (Between 30 to 60 Years Old)
Interventions: Protein Rich Foods; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 30 Years to 60 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Austin, Texas

Conditions: ADHD With Sleep Onset Insomnia
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stress, Anxiety, Autonomic Dysregulation, Acoustic Stimulation, Hyperarousal, Health Personnel
Interventions: Cereset Research; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 100 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Insomnia
Interventions: Defined CBD, Placebo; Drug
Lead sponsor: Defined Research; Industry
Eligibility: 25 Years to 70 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sleep Initiation and Maintenance Disorders, Insomnia
Interventions: eplivanserin (SR46349), placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 1,155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Insomnia
Interventions: JNJ-42847922, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Hollywood, Florida

Search by objective public record fields.

Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD

Treating Chronic Insomnia in Breast Cancer Patients

Tart Cherry Juice for Sleep in Older Adults With Insomnia: A Pilot Study of Feasibility and Comprehensive Mechanisms

Infant Behavioral Sleep Intervention: Comparative Efficacy

A Study of a Sleep Supplement to Improve Sleep in Women Going Through Menopause

The Feasibility of Home-Based Measurement of Circadian Timing for Veterans With TBI and Insomnia

Bonafide Sleep Supplement for Menopausal Women With Impaired Sleep

Testing an Online Insomnia Intervention

Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia

Training in Evidence-based Treatments in Psycho-Oncology

Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors

Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers

Digital CBT for Insomnia and Depression

Eszopiclone Treatment & Cortisol Responsivity

Effects of an Interdisciplinary Fitness and Social Engagement Intervention

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia

Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia

Cereset Research Long-Term Healthcare Worker Study

Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity